Stock listing

Cardiff Oncology, Inc.

Selected listing: A2P4GU · LS · EUR · DE

Cardiff Oncology, Inc. (Lang & Schwarz: A2P4GU), Health Technology. Latest release Sep 14, 2026: Cardiff Oncology and Nerviano Medical Sciences Amend…

A2P4GU:LSEURDEUpdated September 25, 2026

Ticker: Lang & Schwarz: A2P4GU
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

About Cardiff Oncology, Inc.

Cardiff Oncology, Inc. (CRDF) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Cardiff Oncology, Inc.

Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement

September 14, 2026

Cardiff Oncology to Participate in September 2026 Conferences

September 2, 2026

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

August 11, 2026

Cardiff Oncology Announces $10 Million Registered Direct Offering

July 15, 2026

Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting

June 2, 2026

All Cardiff Oncology, Inc. news →

Events

Replays

Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call
Thu, Feb 27, 2025 · 08:30 PM ET
Watch
Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call
Thu, Aug 08, 2024 · 04:30 PM ET
Watch
Cardiff Oncology, Inc. (CRDF) Q1 2024 Earnings Call
Thu, May 02, 2024 · 04:30 PM ET
Watch

Research Cardiff Oncology, Inc.

Cardiff Oncology, Inc. company profile

View the public company page for Cardiff Oncology, Inc. on 6ix.

Cardiff Oncology, Inc. news

Read company news and market updates connected to Cardiff Oncology, Inc..

Cardiff Oncology, Inc. investor events

Find investor webinars, events, and replay context for Cardiff Oncology, Inc..